Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol

Archives of Ophthalmology
P RáczL Z Bito

Abstract

To determine whether once-daily, in the morning, topical application of the new ocular hypotensive prostaglandin analogue, latanoprost, yields nocturnal intraocular pressure (IOP) reduction similar to its diurnal IOP reducing efficacy. Placebo- controlled, randomized, and double-masked study on hospitalized patients with ocular hypertension or glaucoma. Patients in group 1 (n=9) were maintained on twice-daily applications of 0.5% timolol maleate. Patients in group 2 (n=10) terminated their timolol treatment 3 weeks before the beginning of the study. In both groups the test drug (0.005% latanoprost) and its vehicle (placebo) was applied by hospital staff every morning for 9 days. After 4 days of ambulatory treatment, patients were hospitalized, and IOP values were obtained in the supine and sitting positions with a handheld electronic tonometer (Tono-Pen XL, Bio-Rad, Glendale, Calif) and a Goldmann's applanation tonometer, covering every 2-hour interval, around the clock, but not more than at four time points per day during a 5-day period. The mean nocturnal IOPs (Goldmann's applanation tonometer) collected for 5 days were mean +/-SEM 17.9+/-0.6 vs 20.2+/-0.6 mm Hg and 16.8+/-0.3 vs 20.6+/-0.5 mm Hg for the study vs the control ...Continue Reading

Citations

Aug 31, 1999·Survey of Ophthalmology·C E Margo
Sep 3, 2002·Survey of Ophthalmology·Remo SusannaYoshiaki Kitazawa
Mar 16, 2004·Survey of Ophthalmology·Thomas R WaltersUNKNOWN Bimatoprost Circadian IOP Study Group
Oct 17, 2006·Wiener medizinische Wochenschrift·Hemma Resch, Gerhard Garhofer
Dec 4, 2001·American Journal of Ophthalmology·S L MansbergerG A Cioffi
Feb 22, 2012·Expert Opinion on Pharmacotherapy·Maurizio DigiuniLuca Rossetti
Jun 29, 2013·Expert Opinion on Pharmacotherapy·Anastasios Gp KonstasMurat Irkec
Jul 2, 2005·Expert Opinion on Emerging Drugs·Abbot F Clark, Iok-Hou Pang
Apr 3, 2001·Expert Opinion on Investigational Drugs·C Lindén
Sep 15, 2004·American Journal of Ophthalmology·John H K LiuRobert N Weinreb
Feb 1, 1997·Survey of Ophthalmology·M DiestelhorstS Nagasubramanian
Aug 27, 1999·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·H H LeD Hartenbaum
Oct 22, 2008·International Ophthalmology Clinics·Casey C Geringer, Nauman R Imami
Feb 27, 2001·Current Opinion in Ophthalmology·R Susanna, F A Medeiros
Jun 11, 2003·Drugs & Aging·Caroline M PerryTim Ibbotson
Apr 17, 2003·European Journal of Ophthalmology·E RavinetR Brignoli
Sep 2, 2003·European Journal of Ophthalmology·R SihotaV Gulati
May 3, 2000·Seminars in Ophthalmology·T W Hejkal, C B Camras
Nov 27, 2007·Expert Opinion on Pharmacotherapy·Jess T Whitson
Sep 3, 2002·Survey of Ophthalmology·Laszlo Z Bito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.